CHOREO, LLC

Position in NVS — Novartis AG

CIK 1679031 ROCKFORD, IL

Position in NVS

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$6,142,326

+$244,496 QoQ

Shares Held

39,193

+1.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#236

of 1,598 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CHOREO, LLC holds $158,372,063 across 15 Drug Manufacturers - General names. NVS ranks #7 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	29,798	$35,740,618
2	JNJ	Johnson & Johnson	140,570	$35,700,562
3	ABBV	AbbVie Inc.	105,320	$26,502,724
4	MRK	Merck & Co., Inc.	129,070	$16,585,495
5	BMY	Bristol Myers Squibb Co	128,422	$7,399,675
6	AMGN	Amgen Inc	18,320	$6,634,038
7	NVS	Novartis AG This page	39,193	$6,142,326
8	NVO	Novo Nordisk A S	121,486	$5,824,038

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,142,326	39,193	+1.5%	Shares	Sole	2026-08-04
2026-03-31	$5,897,830	38,611	+16.2%	Shares	Sole	2026-05-13
2025-12-31	$4,580,455	33,223	-3.9%	Shares	Sole	2026-01-23
2025-09-30	$4,433,385	34,571	+18.9%	Shares	Sole	2025-11-12
2025-06-30	$3,518,728	29,078	+2.8%	Shares	Sole	2025-08-13
2025-03-31	$3,152,988	28,283	-8.1%	Shares	Sole	2025-05-06
2024-12-31	$2,995,882	30,787	-2.1%	Shares	Sole	2025-01-27
2024-09-30	$3,616,113	31,439	+9.1%	Shares	Sole	2024-11-07
2024-06-30	$3,068,177	28,820	+285.0%	Shares	Sole	2024-08-07
2024-03-31	$724,024	7,485	+46.6%	Shares	Sole	2024-05-02
2023-12-31	$515,653	5,107	—	Shares	Sole	2024-02-05
No filing history on record for this holder in this stock.